Patients ( N = 100 ) with mixed dyslipidemia on a standard statin dose ( 10-40mg simvastatin or 10-20mg atorvastatin or 5-10mg rosuvastatin ) who had not achieved lipid targets were randomized to switch to the highest dose of rosuvastatin ( 40mg/day ) or to add-on-statin extended release nicotinic acid ( ER-NA ) / laropiprant ( LRPT ) ( 1000/20mg/day for the first 4weeks followed by 2000/40mg/day for the next 8weeks ) or to add-on-statin micronized fenofibrate ( 200mg/day ) for a total of 3months .